United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Sale of $5.7 Million in Common Shares

• United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Oct. 30, 2026.
• Rothblatt exercised 9,500 stock options at $117.76 per share on the same date, leaving 119,410 stock options held indirectly through a trust.
• Following the transactions, she held 324,443 common shares through the transacting trusts, with another 40,513 shares held directly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000176), on November 02, 2026, and is solely responsible for the information contained therein.